| Literature DB >> 15733323 |
Seyd Mansour Razavi1, Mohammad Ibrahimpoor, Ahmad Sabouri Kashani, Ali Jafarian.
Abstract
BACKGROUND: Abdominal surgical site infections are among the most common complications of inpatient admissions and have serious consequences for outcomes and costs. Different risk factors may be involved, including age, sex, nutrition and immunity, prophylactic antibiotics, operation type and duration, type of shaving, and secondary infections. This study aimed to determine the risk factors affecting abdominal surgical site infections and their incidence at Imam Khomeini, a major referral teaching hospital in Iran.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15733323 PMCID: PMC555554 DOI: 10.1186/1471-2482-5-2
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Population Distribution based on the type of operation and SSI Incidence.
| splenectomy | 24 | 3 | -- | -- |
| cholecystectomy | 272 | 33.9 | 25 | 9.2 |
| umbilical hernia | 35 | 4.4 | 5 | 14.3 |
| appendicitis | 132 | 16.5 | 19 | 14.4 |
| stomach cancer | 58 | 7.2 | 23 | 39.7 |
| Excision biopsy | 15 | 1.9 | -- | -- |
| laparotomy | 142 | 17.7 | 25 | 17.6 |
| cystectomy | 9 | 1.1 | 4 | 44.4 |
| colon cancer | 24 | 3 | 14 | 58.3 |
| colostomy | 15 | 1.9 | 10 | 66.7 |
| laparoscopy | 18 | 2.2 | -- | -- |
| abdominal mass | 10 | 1.2 | 2 | 20 |
| ileostomy | 10 | 1.2 | 5 | 50 |
| Intestinal adhesion | 5 | 0.6 | 4 | 80 |
| others | 33 | 4.2 | 4 | 12.1 |
| total | 802 | 100 | 140 | 17.4 |
SSI Distribution based on the factors involved.
| 4 | 3.7 | 103 | 96.3 | 107 | 100 | |||
| 102 | 18.1 | 462 | 81.9 | 564 | 100 | |||
| 33 | 25.2 | 98 | 74.8 | 131 | 100 | |||
| 61 | 15.1 | 344 | 84.9 | 405 | 100 | |||
| 78 | 19.6 | 319 | 80.4 | 397 | 100 | |||
| 5 | 4.6 | 104 | 95.4 | 109 | 100 | |||
| 9 | 4.2 | 205 | 95.8 | 214 | 100 | |||
| 115 | 31.3 | 252 | 68.7 | 367 | 100 | |||
| 10 | 8.9 | 102 | 91.1 | 112 | 100 | |||
| 29 | 14.9 | 166 | 85.1 | 195 | 100 | |||
| 110 | 18.1 | 497 | 81.9 | 607 | 100 | |||
| 9 | 5.4 | 157 | 94.6 | 166 | 100 | |||
| 121 | 19.5 | 501 | 80.5 | 622 | 100 | |||
| 9 | 64.3 | 5 | 35.7 | 14 | 100 | |||
| 24 | 11.7 | 181 | 88.3 | 205 | 100 | |||
| 100 | 18.6 | 439 | 81.4 | 539 | 100 | |||
| 15 | 25.9 | 43 | 74.1 | 58 | 100 | |||
| 29 | 14.5 | 171 | 85.5 | 200 | 100 | |||
| 110 | 18.3 | 492 | 81.7 | 602 | 100 | |||
| 80 | 13.9 | 497 | 86.1 | 577 | 100 | |||
| 59 | 26.2 | 166 | 76.8 | 255 | 100 | |||
| 10 | 17.2 | 48 | 82.8 | 58 | 100 | |||
| 73 | 16 | 383 | 84 | 456 | 100 | |||
| 42 | 19.5 | 173 | 80.5 | 215 | 100 | |||
| 14 | 19.2 | 59 | 80.8 | 73 | 100 | |||
SSI Distribution based on the type of prophylactic antibiotic administered.
| variables SSI | cefazolin | ceftriaxone | Metronidazole | cephalothin | Gentimicine | Ampicillin | ||||||||||||||||||
| A | NA | A | NA | A | NA | A | NA | A | NA | A | NA | |||||||||||||
| A | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % |
| positive | 42 | 12.1 | 97 | 21.3 | 73 | 24.5 | 66 | 13.1 | 79 | 24 | 60 | 12.7 | 19 | 17 | 120 | 17.4 | 70 | 30.4 | 69 | 12.1 | 5 | 50 | 134 | 16.9 |
| negative | 305 | 87.9 | 358 | 78.7 | 225 | 75.5 | 438 | 86.9 | 250 | 76 | 413 | 87.3 | 93 | 83 | 570 | 82.6 | 160 | 69.6 | 503 | 87.9 | 5 | 50 | 658 | 83.1 |
| total | 347 | 100 | 455 | 100 | 298 | 100 | 504 | 100 | 329 | 100 | 473 | 100 | 112 | 100 | 690 | 100 | 230 | 100 | 572 | 100 | 10 | 100 | 792 | 100 |
| P-Value | P = 0.001 | P < 0.001 | P < 0.001 | P = 1.000 | P < 0.001 | P = 0.018 | ||||||||||||||||||
A = applied
NA = not applied